130 related articles for article (PubMed ID: 9459010)
21. Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor.
Witkin JM; Brave S; French D; Geter-Douglass B
J Pharmacol Exp Ther; 1995 Dec; 275(3):1267-73. PubMed ID: 8531091
[TBL] [Abstract][Full Text] [Related]
22. Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures.
Boje KM; Wong G; Skolnick P
Brain Res; 1993 Feb; 603(2):207-14. PubMed ID: 8096423
[TBL] [Abstract][Full Text] [Related]
23. [3H]5,7-dichlorokynurenic acid recognizes two binding sites in rat cerebral cortex membranes.
Mugnaini M; Antolini M; Corsi M; van Amsterdam FT
J Recept Signal Transduct Res; 1998; 18(2-3):91-112. PubMed ID: 9651880
[TBL] [Abstract][Full Text] [Related]
24. Glycine binding sites of presynaptic NMDA receptors may tonically regulate glutamate release in the rat visual cortex.
Li YH; Han TZ
J Neurophysiol; 2007 Jan; 97(1):817-23. PubMed ID: 17093111
[TBL] [Abstract][Full Text] [Related]
25. Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions.
Jansen M; Dannhardt G
Eur J Med Chem; 2003; 38(7-8):661-70. PubMed ID: 12932897
[TBL] [Abstract][Full Text] [Related]
26. [3H]5,7-dichlorokynurenic acid, a novel radioligand labels NMDA receptor-associated glycine binding sites.
Baron BM; Siegel BW; Slone AL; Harrison BL; Palfreyman MG; Hurt SD
Eur J Pharmacol; 1991 Feb; 206(2):149-54. PubMed ID: 1829684
[TBL] [Abstract][Full Text] [Related]
27. N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents.
Lynch DR; Anegawa NJ; Verdoorn T; Pritchett DB
Mol Pharmacol; 1994 Mar; 45(3):540-5. PubMed ID: 7511781
[TBL] [Abstract][Full Text] [Related]
28. A glycine receptor antagonist, strychnine, blocked NMDA receptor activation in the neonatal mouse neocortex.
Miyakawa N; Uchino S; Yamashita T; Okada H; Nakamura T; Kaminogawa S; Miyamoto Y; Hisatsune T
Neuroreport; 2002 Sep; 13(13):1667-73. PubMed ID: 12352624
[TBL] [Abstract][Full Text] [Related]
29. Synergism between the NMDA receptor antagonistic effects of ifenprodil and the glycine antagonist, 7-chlorokynurenate, in vivo.
Voltz C; Fage D; Carter C
Eur J Pharmacol; 1994 Apr; 255(1-3):197-202. PubMed ID: 8026544
[TBL] [Abstract][Full Text] [Related]
30. Tonic facilitation of glutamate release by glycine binding sites on presynaptic NR2B-containing NMDA autoreceptors in the rat visual cortex.
Li YH; Han TZ; Meng K
Neurosci Lett; 2008 Feb; 432(3):212-6. PubMed ID: 18248890
[TBL] [Abstract][Full Text] [Related]
31. Regulation by glycine, Mg2+ and polyamines of the N-methyl-D-aspartate-induced locomotion in the neonatal rat spinal cord in vitro.
Bertrand S; Cazalets JR
Neuroscience; 1999; 94(4):1199-206. PubMed ID: 10625059
[TBL] [Abstract][Full Text] [Related]
32. Complex polyamine effects on [3H]MDL 105,519 binding to the NMDA receptor glycine site.
Sharma TA; Reynolds IJ
Neurochem Int; 1998 Aug; 33(2):155-9. PubMed ID: 9761459
[TBL] [Abstract][Full Text] [Related]
33. Kynurenic acid does not protect against nicotine-induced seizures in mice.
Kiś J; Czuczwar M; Zielińska E; Bojar I; Czuczwar SJ; Turski WA
Pol J Pharmacol; 2000; 52(6):477-80. PubMed ID: 11334243
[TBL] [Abstract][Full Text] [Related]
34. Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site.
Di Fabio R; Capelli AM; Conti N; Cugola A; Donati D; Feriani A; Gastaldi P; Gaviraghi G; Hewkin CT; Micheli F; Missio A; Mugnaini M; Pecunioso A; Quaglia AM; Ratti E; Rossi L; Tedesco G; Trist DG; Reggiani A
J Med Chem; 1997 Mar; 40(6):841-50. PubMed ID: 9083472
[TBL] [Abstract][Full Text] [Related]
35. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
Widdowson PS; Gyte AJ; Upton R; Wyatt I
Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
[TBL] [Abstract][Full Text] [Related]
36. The glycine site on the NMDA receptor: structure-activity relationships and possible therapeutic applications.
Dannhardt G; Kohl BK
Curr Med Chem; 1998 Aug; 5(4):253-63. PubMed ID: 9668194
[TBL] [Abstract][Full Text] [Related]
37. Induction of feeding by 7-chlorokynurenic acid, a strychnine-insensitive glycine binding site antagonist.
Sorrels TL; Bostock E
Brain Res; 1992 Feb; 572(1-2):265-8. PubMed ID: 1319272
[TBL] [Abstract][Full Text] [Related]
38. Strychnine-insensitive glycine/NMDA sites are altered in two stress models of depression.
Nowak G; Ossowska G; Jopek R; Papp M
Pol J Pharmacol; 1998; 50(4-5):365-9. PubMed ID: 10091723
[TBL] [Abstract][Full Text] [Related]
39. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
Irifune M; Shimizu T; Nomoto M; Fukuda T
Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
[TBL] [Abstract][Full Text] [Related]
40. Behavioral and neurochemical actions of the strychnine-insensitive glycine receptor antagonist, 7-chlorokynurenate, in rats.
Kretschmer BD; Bubser M; Schmidt WJ
Eur J Pharmacol; 1995 Jun; 280(1):37-45. PubMed ID: 7498252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
